FDA Approved: SODIUM PHENYLACETATE AND SODIUM BENZOATE — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved an original application for sodium phenylacetate and sodium benzoate to treat hyperammonemia due to urea cycle disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperammonemia
• Urea Cycle Disorders

Drugs mentioned

• Sodium phenylacetate and sodium benzoate (sodium phenylacetate and sodium benzoate)

Snippet

ORIG AP for SODIUM PHENYLACETATE AND SODIUM BENZOATE (SODIUM PHENYLACETATE AND SODIUM BENZOATE)